Pharmacokinetic study of oxaliplatin iv chronomodulated infusion combined with 5-fluorouracil iv continuous infusion in the treatment of advanced colorectal cancer

By Cattel L.   La Grotta G.   Infante L.   Passera R.   Arpicco S.   Brusa P.   Bumma C.  

Il Farmaco, Vol. 58, Iss. 12, 2003-12 ,pp. : 1333-1338

Elsevier

Access to resources Recommend Favorite

Phase I trial of combined irinotecan and oxaliplatin given every three weeks to patients with metastatic colorectal cancer

By Hoff Paulo   Saad Everardo   Pazdur Richard   Wolff Robert   Lassere Yvonne   Bogaard Karla   Abbruzzese James  

Investigational New Drugs, Vol. 22, Iss. 3, 2004-08 ,pp. : 307-313

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of S-1 plus irinotecan and oxaliplatin in heavily-treated patients with metastatic colorectal cancer

By Kim Sun   Hong Yong   Kim Byung   Park Ji   Choi Hyo   Jeong Seung-Yong   Kim Dae   Hong Chang   Sohn Dae   Jung Kyung  

Investigational New Drugs, Vol. 27, Iss. 3, 2009-06 ,pp. : 269-274

Springer Publishing Company

Access to resources Recommend Favorite

Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin

By Gordon Michael A   Zhang Wu   Yang Dongyun   Iqbal Syma   El-Khouiery Anthony   Nagashima Fumio   Lurje Georg   Labonte Melissa   Wilson Peter   Sherrod Andy   Ladner Robert D   Lenz Heinz-Josef  

Pharmacogenomics, Vol. 12, Iss. 1, 2011-01 ,pp. : 27-39

Future Medicine

Access to resources Recommend Favorite

Differential Pharmacokinetics of Ganitumab in Patients With Metastatic Pancreatic Cancer Versus Other Advanced Solid Cancers

By  

Clinical Pharmacology In Drug Development, Vol. 2, Iss. 4, 2013-10 ,pp. : 367-378

John Wiley & Sons Inc

Access to resources Recommend Favorite